Senseonics Holdings (NYSEAMERICAN:SENS)’s share price traded up 5.9% on Monday . The stock traded as high as $4.49 and last traded at $4.49. 3,063,000 shares were traded during mid-day trading, an increase of 264% from the average session volume of 842,417 shares. The stock had previously closed at $4.24.
Several equities analysts have recently weighed in on the company. Canaccord Genuity restated a “buy” rating and issued a $5.00 target price on shares of Senseonics in a research report on Friday, May 18th. BTIG Research restated a “buy” rating and issued a $5.00 target price on shares of Senseonics in a research report on Thursday, June 7th. Guggenheim assumed coverage on Senseonics in a research report on Tuesday, April 3rd. They issued a “buy” rating and a $6.00 target price on the stock. Finally, Craig Hallum assumed coverage on Senseonics in a research report on Monday, June 11th. They issued a “buy” rating and a $7.00 target price on the stock. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Senseonics currently has a consensus rating of “Buy” and a consensus price target of $5.75.
The company has a current ratio of 2.93, a quick ratio of 2.81 and a debt-to-equity ratio of 0.76.
In other Senseonics news, COO Mukul Jain sold 24,294 shares of Senseonics stock in a transaction on Friday, April 6th. The stock was sold at an average price of $3.75, for a total value of $91,102.50. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Douglas A. Roeder sold 980,389 shares of Senseonics stock in a transaction on Friday, June 15th. The shares were sold at an average price of $4.02, for a total value of $3,941,163.78. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,567,437 shares of company stock worth $6,192,799. 34.10% of the stock is currently owned by company insiders.
A number of large investors have recently bought and sold shares of SENS. Raymond James Financial Services Advisors Inc. raised its position in Senseonics by 38.9% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 487,175 shares of the company’s stock valued at $1,296,000 after purchasing an additional 136,425 shares during the period. BlueCrest Capital Management Ltd acquired a new stake in shares of Senseonics in the fourth quarter valued at $198,000. Goldman Sachs Group Inc. acquired a new stake in shares of Senseonics in the fourth quarter valued at $108,000. Perceptive Advisors LLC grew its stake in shares of Senseonics by 130.0% in the fourth quarter. Perceptive Advisors LLC now owns 115,000 shares of the company’s stock valued at $306,000 after buying an additional 65,000 shares in the last quarter. Finally, California State Teachers Retirement System acquired a new stake in shares of Senseonics in the fourth quarter valued at $651,000. Institutional investors own 30.66% of the company’s stock.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.